Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer

NCT06398639 is registered in ClinicalTrials.gov with Adam S. Kibel, MD as lead sponsor.

NCT NCT06398639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06398639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Lead sponsor
Adam S. Kibel, MD
Phase
Not applicable
Overall status
Recruiting
Start date
May 7, 2024
Completion date
April 30, 2030
Enrollment
1,500 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

polygenic risk score, prostate cancer